These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8518234)

  • 1. Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells.
    Donato NJ; Yan DH; Hung MC; Rosenblum MG
    Cell Growth Differ; 1993 May; 4(5):411-9. PubMed ID: 8518234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
    Nishikawa K; Rosenblum MG; Newman RA; Pandita TK; Hittelman WN; Donato NJ
    Cancer Res; 1992 Sep; 52(17):4758-65. PubMed ID: 1380890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive and negative selection for tumor necrosis factor responsiveness reveals an inhibitory role for EGF receptor in TNF-induced antiproliferation.
    Nishikawa K; Rotbein J; Vijjeswarapu D; Owen-Schaub L; Rosenblum MG; Donato NJ
    Lymphokine Cytokine Res; 1994 Feb; 13(1):37-45. PubMed ID: 8186323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
    Donato NJ; Perez M; Kang H; Siddik ZH; Ling YH; Perez-Soler R
    Clin Cancer Res; 2000 Jan; 6(1):193-202. PubMed ID: 10656450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor.
    Perez M; Haschke B; Donato NJ
    Oncogene; 1999 Jan; 18(4):967-78. PubMed ID: 10023672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of epidermal growth factor receptor tyrosine phosphorylation by tumor necrosis factor correlates with loss of cytotoxic activity.
    Perez M; Donato NJ
    J Interferon Cytokine Res; 1996 Apr; 16(4):307-14. PubMed ID: 9162524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
    Donato NJ; Rosenblum MG; Steck PA
    Cell Growth Differ; 1992 May; 3(5):259-68. PubMed ID: 1378752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME-180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II.
    Coffman FD; Green LM; Godwin A; Ware CF
    J Cell Biochem; 1989 Feb; 39(2):95-105. PubMed ID: 2541144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
    Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
    Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
    Fujii K; Furukawa F; Matsuyoshi N
    Exp Cell Res; 1996 Feb; 223(1):50-62. PubMed ID: 8635495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells.
    Kim JS; Steck PA; Gallick GE; Lee JS; Blick M; Hong WK; Lotan R
    J Natl Cancer Inst Monogr; 1992; (13):101-10. PubMed ID: 1389683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells.
    Mawatari M; Kohno K; Mizoguchi H; Matsuda T; Asoh K; Van Damme J; Welgus HG; Kuwano M
    J Immunol; 1989 Sep; 143(5):1619-27. PubMed ID: 2547871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors.
    Mishra S; Mathur R; Hamburger AW
    Lymphokine Cytokine Res; 1994 Apr; 13(2):77-83. PubMed ID: 8061118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431.
    Meuillet EJ; Kroes R; Yamamoto H; Warner TG; Ferrari J; Mania-Farnell B; George D; Rebbaa A; Moskal JR; Bremer EG
    Cancer Res; 1999 Jan; 59(1):234-40. PubMed ID: 9892212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor gene expression, protein kinase activity, and terminal differentiation of human malignant epidermal cells.
    King I; Sartorelli AC
    Cancer Res; 1989 Oct; 49(20):5677-81. PubMed ID: 2790786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of EGF receptor by tumor necrosis factor-alpha in human hepatocellular carcinoma HepG2 cells.
    Wang D; Yang EB; Cheng LY
    Anticancer Res; 1996; 16(5A):3001-6. PubMed ID: 8917420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity.
    Donato NJ; Gallick GE; Steck PA; Rosenblum MG
    J Biol Chem; 1989 Dec; 264(34):20474-81. PubMed ID: 2555361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.